MedPath

Evaluation the effect of vitamin D3 in improvement clinical parameters of patients with chronic periodontitis-clinical trial

Phase 4
Conditions
K05.3
Chronic periodontitis.
Chronic periodontitis
Registration Number
IRCT20221212056786N3
Lead Sponsor
Yazd University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Female
Target Recruitment
32
Inclusion Criteria

female
Has at least 20 teeth
Blood vitamin D levels below 30 ng/ml (normal level is = 30 ng/ml).
Healthy
Between 30 and 45 years

Exclusion Criteria

Recent antibiotic therapy
Taking vitamin D supplements
Use of corticosteroids or immunosuppressive drugs
Taking aspirin tablets
NSAID use
Taking bisphosphonates or hormone therapy
Patients who were in menopause or pregnancy
Bone diseases
Patient with history of infective endocarditis, congenital problem or acquired heart defects
Immunodeficiency
History of diabetes
Calcium deficiency
Other systemic conditions that may affect the periodontium and the treatment protocol

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Clinical attachment loss. Timepoint: At the beginning of the study and 12 weeks after the start of vitamin D intake. Method of measurement: Williams periodontal probe.
Secondary Outcome Measures
NameTimeMethod
Probing depth. Timepoint: At the beginning of the study and 12 weeks after the start of vitamin D intake. Method of measurement: Williams periodontal probe.;Bleeding on probing. Timepoint: At the beginning of the study and 12 weeks after the start of vitamin D intake. Method of measurement: Williams periodontal probe.
© Copyright 2025. All Rights Reserved by MedPath